Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Letter from the CEO
Dear Stockholders, Board Members, Partners, and Employees:
Healthcare of Today was founded with a vision.
That vision was to consistently provide high quality healthcare products, services, and education, and to deliver them with compassion. Looking at what our family of businesses has become, I am proud of our history and optimistic about our future.
Healthcare has become a mainstream issue and it is one that touches each of our lives. Within the healthcare industry there is not only opportunity, but also an unprecedented amount of responsibility. Healthcare of Today is always ready to meet the challenges of a changing healthcare environment. The Company is particularly exciting to me because of its unique competitive attributes, including an exceptional leadership position in several growth markets, a firm commitment to the continual improvement of our operational performance, and a resourceful vertical integration strategy that allows our companies to be nurtured by one another’s strengths. That we are supported by a great set of stockholders, board members, partners, and employees ensures that this success will be long-lived.
Our companies each demonstrate industry leadership and a vision for their future. Fortunately, at Healthcare of Today, the whole is even greater than the sum of its parts. And, as an organization, we are always looking for new and innovative ways to approach old issues. How can we best care for a growing senior population? How can we ensure that we give people access to the healthcare they need? How can we best use science to solve the world’s most pressing health issues and cure diseases? Every day our Healthcare of Today companies tackle these issues and many more.
At Healthcare of Today, we believe that through our daily work we can contribute to both the betterment of public health and the healthcare industry as a whole. Healthcare of Today looks to deliver new value to the healthcare industry through its expanding line of businesses, companies that each see clearly how they are part of—and contribute to—the communities they exist in. I will continue to see to it that we “do good business by doing good”. And Healthcare of Today will continue to demonstrate that high quality healthcare absolutely has a place in a for-profit world.
While we are proud of what we have already done, there is much yet to do. Every step we take will continue to strategically support our efforts to be the preeminent healthcare company, the one you choose for your family.
I thank you for your involvement in this mission and for your continued support as we look boldly towards a promising future.
Best wishes and good health,
Henry Jan
CEO, Healthcare of Today
http://www.healthcareoftoday.com/AboutUs
Liking this excerpt of a recent PR:
a listing application with NASDAQ for the common shares of the surviving entity in the merger. Under the terms of the merger, Healthcare of Today, Inc. and SK3 Group will both merge into a newly-formed Nevada corporation, Healthcare of Today, Inc., which has been formed for that purpose and which will be the surviving entity.
SK3 Group's Parent Company Healthcare of Today Acquires Advanced Human Tissue Technology Producer for $40 Million
On Thursday December 17, 2009, 9:00 am EST
MIAMI, FLORIDA--(Marketwire - 12/17/09) - SK3 Group, Inc.'s (PINK SHEETS:SKTO - News) new parent company Healthcare of Today, Inc. (www.healthcareoftoday.com/) has today announced the acquisition of Xenotis Pty Ltd., the Australian-based producer of advanced human tissue engineering technology for $40M.
"Xenotis is leading the world in advanced human tissue engineering. While many companies are interested in this fast-growing market, few have made the clear strides that Xenotis has. The company has working products and a strong distribution network in place around the globe. As we consider how to seamlessly integrate Xenotis into our family of companies, I think there is a particular dynamic to be enjoyed given our relationship with Regenetech, which is the world leader in advanced stem cell research technology," says Healthcare of Today CEO Henry Jan.
The recent growth of the tissue engineering industry has been attributed to the shortage of donors and the desire to avoid rejection. Xenotis has been involved in proprietary tissue scaffolds and processing technology since the late 1980's. Other medical devices and products in the company's tissue engineering portfolio include a range of tissue-engineered grafts, replacement blood vessels, ligaments and heart valves.
Xenotis is well known for its custom-designed biosynthetic graft, produced according to strict specifications for use in peripheral bypass or arteriovenous access. The custom-designed prosthetic material combines the durability of synthetic material with similar hemocompatibility to that of a natural blood vessel. This stands in contrast to pure biological grafts, which are made from recycled blood vessels or other recovered tissues.
The prostheses is used when grafting from the patient's own blood vessel is not possible. Among its benefits are that it is non-toxic, non-calcifying, and has medium to long-term functionality, making it a more cost-effective solution. It may also allow the patient to undergo fewer procedures, a distinct advantage for seniors for whom general health considerations increase the risk of repeated surgical procedures. To date, the prostheses has been implanted in tens of thousands of patients across 30 countries, and is produced and sold through one of Xenotis's wholly-owned subsidiaries.
Regenetech, Inc. (http://www.Regenetech.com/), a Houston-based biotechnology company, has established itself as the world leader in advanced adult stem cell technology. It has licensed 13 patents, utilizing its unique relationship with NASA, for the expansion of adult stem cells in a simulated weightless environment, and through its own research efforts has obtained several hundred patents and patent applications throughout the world. With its vast patent portfolio, Regenetech has been able to develop an aggressive international licensing policy, offering its technology and patents across the globe.
Healthcare of Today CEO Henry Jan also says, "Xenotis's work has changed the lives of patients throughout the world. Improving the quality and viability of people's lives is something we are quite passionate about here at Healthcare of Today. Considering that the United States is 50% of the world medical device market, we wholeheartedly support their entry into this market and into the lives of our core customers. We intend on using the relationships that Xenotis has built around the world to expand the reach of the other companies in the Healthcare of Today family so that all can improve the value to the shareholder."
SK3 Group's Parent Company Signs Letter of Intent for Medical Product Developer
On Wednesday March 10, 2010, 9:00 am EST
MIAMI, FL--(Marketwire - 03/10/10) - SK3 Group, Inc.'s (Pinksheets:SKTO - News) parent company, Healthcare of Today, Inc. (www.healthcareoftoday.com/), has announced the signing of a letter of intent with leading edge medical product company DyfucaMed®, LLC ("DyfucaMed®").
DyfucaMed®'s flagship product is the DyfucaMed® Ratio Applicator, a medical biomaterials applicator for performing Autogenous Hematopoetic Tissue Grafts ("AHTG"). Using stem cell technology and controlled application of a concentrated platelet gel, the DyfucaMed® Ratio Applicator allows the body to use its own healing mechanisms for therapeutic benefits and accelerated healing. Platelet Gel has received attention as the medical choice for athletes who require a rapid recovery, including NFL player Hines Ward. The use of a platelet gel applicator is appealing for a number of markets requiring aggressive recovery, including the military and veterinary markets.
DyfucaMed® creates user-driven medical solutions, consulting with medical professionals who regularly use tissue grafts to gain insight into market needs during various stages of product development. In one example, the DyfucaMed® Ratio Applicator uses a plastic polycarbonate that is the first disposable applicator to be lipid-resistant and has finger grips to prevent slippage.
The development of the DyfucaMed® Ratio Applicator was inspired by surgeons' increasing recommendation of the use of platelet gel. Platelet gel offers a number of benefits including accelerated tissue regeneration, helping create hemostasis, reducing pain, helping prevent infection, and reducing the chance of adhesions. Clinical uses of autologous platelet gel are numerous and include plastic surgery, orthopedic surgery including hip replacements, neurosurgery, major vascular surgery, cardio-thoracic surgery, oral surgery, and chronic wounds such as diabetic foot ulcers.
CEO of DyfucaMed® Lawrence Williams says, "The DyfucaMed® Ratio Applicator improves healing time and prevents bruising. Platelet gel can often make a dramatic difference, such as the difference between a patient having a limb amputated or healing the sore and moving on. We are thrilled to bring our products into the Healthcare of Today family of businesses and we share its passion for finding new and innovative ways to improve patient outcomes."
Healthcare of Today VP of International Business Development Daniel McKeown says, "DyfucaMed® has taken the time to understand what doctors say they need to help their patients heal faster, and has developed those tools. We are thrilled to bring their cutting-edge line of products on board with Healthcare of Today and to vertically integrate them into our family of companies so our patients and businesses across the board can benefit from their ground-breaking product line. We look forward to working with DyfucaMed® to find new ways to restore our patients, young and old, to their best health."
Do it up! Gettin' dizzy and overwhelmed with anticipation the more DD and reading being done.
There has got to be more great news, etc., coming soon to bring it all together.
SK3 Group Announces Signing of Merger Agreement with Healthcare of Today, and Correction of Prior Acquisition Announcement
On Friday January 8, 2010, 2:04 am EST
MIAMI, FLORIDA--(Marketwire - 01/08/10) - SK3 Group, Inc. (PINK SHEETS:SKTO - News) today announces that it has entered into a definitive Agreement and Plan of Merger with Healthcare of Today, Inc., completing the terms of the previously announced letter of intent. Closing of the merger is subject to the completion of audits of SK3 and Healthcare of Today, Inc., the effectiveness of an S-4 registration statement to be filed with the SEC, and acceptance of a listing application with NASDAQ for the common shares of the surviving entity in the merger. Under the terms of the merger, Healthcare of Today, Inc. and SK3 Group will both merge into a newly-formed Nevada corporation, Healthcare of Today, Inc., which has been formed for that purpose and which will be the surviving entity.
In addition, SK3 Group previously announced that Healthcare of Today, Inc. has acquired MacuCLEAR, Inc., a pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye. That announcement was incorrect. Healthcare of Today has, in fact, entered into a letter of intent for such an acquisition, but has not yet completed a definitive acquisition agreement or closed on the acquisition.
Healthcare of Today (www.healthcareoftoday.com), based in Burbank, California, is a vertically-integrated healthcare holding company. Founded in 2008, it has since acquired a number of companies, many specializing in the senior care industry. Its subsidiaries are engaged in a wide range of businesses including: nurse staffing, residential care facilities for the elderly, home healthcare services, home healthcare equipment sales, healthcare information technology, medical equipment, healthcare consulting, insurance, data security, advanced human tissue engineering, and more.
It does look amazing! Think there is a lot more forthcoming soon here 'vegas'?
Posted by: vegaseagle Date: Friday, March 12, 2010 3:06:37 PM
In reply to: None Post # of 3088
REFOCUS TIME:
Last few news events out takes: Houston, TX, Feb 17, 2010 (M2 PRESSWIRE via COMTEX) -- In December 2009 Healthcare of Today, Inc.announced the acquisition of Xenotis Pty Ltd. to its biotech division, the Australian-based producer of advanced human tissue engineering technology for $40M and now has been identified as one of the assets that will be included in the new bio-tech division of Guardian Angel Group (Pinsheets: GAGI).
"Xenotis is leading the world in advanced human tissue engineering. While many companies are interested in this fast-growing market, few have made the clear strides that Xenotis has. The company has working products and a strong distribution network in place around the globe. As we consider how to seamlessly integrate Xenotis into our biotech division, I think there is a particular dynamic to be enjoyed given our relationship with Regenetech, which is the world leader in advanced stem cell research technology," said Healthcare of Today CEO Henry Jan.
Houston, TX, Feb 18, 2010 (M2 PRESSWIRE via COMTEX) -- Guardian Angel Group Inc's (Pinsheets: GAGI) president John Gonzalez would like to express his appreciation for the ongoing patients and understanding of all involved with the merger as well as the shareholders of Guardian Angel Group Inc. Mr. Gonzalez stated today, " I am excited what this merger between our two companies represents to our shareholders current and in the future." Gonzalez concluded, "I never would have imagined that I would see a merger of this magnitude come together in my tenure while fitting so well to our overall business structure and management philosophies, we as the board of directors are doing our level best and will continue to keep everyone involved apprised of the details as they develop."
The company still believes that they are on schedule and urge all shareholders to visit the two company's websites for up to date information.
Houston, TX, Feb 22, 2010 (M2 PRESSWIRE via COMTEX) -- Guardian Angel Group Inc's (Pinsheets: GAGI) president John Gonzalez while chairing the board of directors for the last four months will be stepping down after the pending merger is complete. Mr. Gonzalez stated, "While I have extremely enjoyed my position on the board of directors it is now time for me to step aside for a new direction of growth and prosperity for the company and it's shareholders." Mr. Gonzales concluded, "I have been privy to the development's concerning the ongoing structure of the company's board of directors and new biotech division, I am excited what the future holds for the company's shareholders and our company's asset base. I believe our shareholders as well as the medical community will be impressed with the list of the new board members and our biotech division ongoing. I also believe that all involved will be equally impressed with the professionalism and leadership that Healthcare of Today Inc. brings to our future as a leader in the Medical Biotech industry."
Chuckle, WOW, thanks 'vegas' alot of good news there.
And SKTO's Parent company has a solid sustained business direction here, don't they?
Healthcare of Today is a network of related businesses. In simple terms, Healthcare of Today acts as a parent to a large family. Each separate company underneath the canopy of our management is guided by the philosophy and direction of HOTI executives and its Board of Directors. While the underlying companies are wholly owned as subsidiaries, they maintain their respective business functions and operate as individual units. So the benefit is that in addition to being an independent business, they are now networked into a whole range of companies from which they can seek additional resources, partnerships, and professional insight from colleagues at the highest levels of various industries.
SKTO parent company:
About Healthcare of Today, Inc.
Healthcare of Today, Inc. (http://www.healthcareoftoday.com/), formed in 2008, acquires and develops companies primarily within the healthcare industry. Through its many subsidiaries, Healthcare of Today owns and operates a number of vertically integrated businesses including: adult stem cell research and development technology, advanced human tissue engineering, medical device technology, medical and home healthcare equipment sales, hospice care, residential care facilities for the elderly, home healthcare services, nurse and therapist staffing, healthcare information technology, healthcare consulting, insurance, medical billing, data protection and security. For more information please visit http://www.healthcareoftoday.com/.
About SK3 Group, Inc.
SK3 Group markets preferred medical services through its facilitation partners to its PEO client base. Corporate information can be found at http://www.sk3groupinc.com.
http://finance.yahoo.com/news/SK3-Groups-Parent-Company-iw-3239700689.html?x=0&.v=1
SKTO parent company:
About Healthcare of Today, Inc.
Healthcare of Today, Inc. (http://www.healthcareoftoday.com/), formed in 2008, acquires and develops companies primarily within the healthcare industry. Through its many subsidiaries, Healthcare of Today owns and operates a number of vertically integrated businesses including: adult stem cell research and development technology, advanced human tissue engineering, medical device technology, medical and home healthcare equipment sales, hospice care, residential care facilities for the elderly, home healthcare services, nurse and therapist staffing, healthcare information technology, healthcare consulting, insurance, medical billing, data protection and security. For more information please visit http://www.healthcareoftoday.com/.
About SK3 Group, Inc.
SK3 Group markets preferred medical services through its facilitation partners to its PEO client base. Corporate information can be found at http://www.sk3groupinc.com.
http://finance.yahoo.com/news/SK3-Groups-Parent-Company-iw-3239700689.html?x=0&.v=1
SKTO - SK3 Group's Parent Company Signs Letter of Intent for Medical Product Developer
On Wednesday March 10, 2010, 9:00 am EST
MIAMI, FL--(Marketwire - 03/10/10) - SK3 Group, Inc.'s (Pinksheets:SKTO - News) parent company, Healthcare of Today, Inc. (http://www.healthcareoftoday.com/), has announced the signing of a letter of intent with leading edge medical product company DyfucaMed®, LLC ("DyfucaMed®").
http://finance.yahoo.com/news/SK3-Groups-Parent-Company-iw-3239700689.html?x=0&.v=1
SKTO - SK3 Group's Parent Company Signs Letter of Intent for Medical Product Developer
On Wednesday March 10, 2010, 9:00 am EST
MIAMI, FL--(Marketwire - 03/10/10) - SK3 Group, Inc.'s (Pinksheets:SKTO - News) parent company, Healthcare of Today, Inc. (http://www.healthcareoftoday.com/), has announced the signing of a letter of intent with leading edge medical product company DyfucaMed®, LLC ("DyfucaMed®").
http://finance.yahoo.com/news/SK3-Groups-Parent-Company-iw-3239700689.html?x=0&.v=1
Quite a bit of buying movement here this last week...
Someone knows something concerning SKTO's future?
Oh yeah, and have to like how the hod($1.94) bumped over that EMA13($1.93), EMA5 is on it's way to cross that showing more expected to come. Was another fair green close today.
May be a blip day this week, but, overall we should see $1.90's possibly $2.00's continuing to, by the week's end. Accumulation indicators have been solid and volume-to-price indicators are showing buying as well, with not too many foolish people wanting to sell here at this level.
Get some more good news and it's gravy. chuckle.
All just in my opinion of course.
Ditto! And with AFYG's nice share structure, the great information provided within the N.I.43-101 report, production starting up shortly, and the appointment of Antoniazzi to CEO, AFYG's pps should follow suit to continued higher and more credible valued market levels, don't you think?
AUTHORIZED: 260,000,000 shares
OUTSTANDING: 51,231,195 shares as of December 10, 2009.
http://www.affinitygold.com/present/Affinity_Technical_Report_Nov_2009_FINAL.pdf
'Junior' gold miners seen as attractive:
Barron's
Sun Feb 14, 2010 4:34pm
NEW YORK (Reuters) - With the gold price reaching record highs recently, stock in so-called "junior" miners has skyrocketed too but may still be viewed as a bargain by some investors, Barron's business newspaper said on Sunday.
Hot Stocks
But it also cautioned that estimated reserves may not always pan out and stocks that once appeared attractive, can sometimes disappoint.
It cited in particular, NovaGold Resources (NG.A) and Seabridge Gold (SA.A), whose valuations have risen ten-fold to about $1 billion each.
The report noted the increased valuations were directly related to the companies' increased estimates of the amount of gold in their reserves.
Barron's said since gold rose to over $1,200 an ounce, the shares of major gold producers, such as Newmont Mining (NEM.N), "went nowhere." But the shares of juniors -- small exploration companies that often have only one property -- had surged.
The newspaper said bulls view NovaGold and Seabridge as cheap at their respective prices of $6 and $25. That represents about $49 and $14 for each ounce of gold they claim to have underground.
PERU: Mining Co's Making a Mint, Tax Free
By Salazar, Milagros
Legal stability contracts that locked in the tax status of nearly two dozen mining companies were signed under the administration of Alberto Fujimori (1990-2000) with the aim of promoting investment. One example of the losses that such contracts represent for government coffers was the 270 million dollars in taxes and royalties that Antamina SA - a joint venture between Swiss-British mining company Xstrata, Anglo-Australian BHP Billiton, Canada's Teck Cominco Limited and Japan's Mitsubishi Corporation - will not have to pay this year.
The government of Alan Garcia recently approved Antamina's new expansion plan, allowing it to reinvest 900 million dollars in profits tax-free under a legal stability contract, which was signed in 1998, went into effect in 2001 and expires in 2015, according to the Ministry of Energy and Mines.
The Compania Minera Antamina SA was established in 1996 to mine zinc, copper, silver and molybdenum in the northwestern Andean department (province) of Ancash.
Economist Humberto Campodonico estimates that the company, which operates the world's largest combined copper and zinc mine, took in earnings of over six billion dollars in the 2006-2009 period.
Since the boom in metals prices began in 2004, the profits of mining companies operating in Peru have skyrocketed.
'Top 10,000 Mining Companies in Peru', put out by the country's leading bilingual publishing company, Peru: Top Publications, reported that Antamina's earnings doubled from nearly 837 million dollars in 2005 to 1.6 billion dollars in 2007.
The publication points out that Peru is now the world's leading producer of silver and tellurium; second in zinc; third in copper, tin and bismuth; fourth in lead, molybdenum and arsenic; sixth in gold and selenium; seventh in indium; thirteenth in cadmium; and seventeenth in iron
Peru’s gold and silver production rose 1.41% and 4.56% in 2009
Lima, Jan. 26 (ANDINA).- Gold production increased 1.41 percent and silver production rose 4.56% in 2009, Peru’s Energy and Mines Ministry (MEM) reported Tuesday.
Peru's Mining, Hydrocarbon Projects May Total $43 Billion By 2017
LIMA -(Dow Jones)- Investments in Peru's mining and hydrocarbon sectors are expected to reach $43 billion within the next seven years, but the most significant new projects are not expected to come on line before 2012.
A report Tuesday by Peru's oil, mining and energy society, the SNMPE, said after a contraction in international demand for metals and hydrocarbons in 2009, projects in Peru's mining and hydrocarbon sectors are expected to reach $43 billion in the next five to seven years.
AMCG - Price Target of $1.44
Amico Games Corp. Rated 'Speculative Buy,' by Beacon Equity Research with a Price Target of $1.44
On Monday February 8, 2010, 2:18 pm EST
DALLAS--(BUSINESS WIRE)--Amico Games Corp. (OTCBB:AMCG - News) has been rated “Speculative Buy,” with a price target of $1.44 by Beacon Analyst, Victor Sula, Ph.D.
The full report is available at http://www.beaconequity.com.
Anyone interested in receiving alerts regarding AMCG research should e-mail members@beaconequity.com with “AMCG” in the subject line.
In the report, the analyst details the interactive entertainment media company, stating:
“The Company plans to accelerate its growth pace in 2010 and 2011 by licensing additional games and technologies and further expanding its registered user base. … We think these growth initiatives could increase the Company’s revenues to more than $10 million and net income to more than $5 million by fiscal year-end 2012.
“The Company’s revenues increased almost 40% in FY 2009 and 61% year-over-year in Q1 2010. In the past 12 months, the number of total game-registered users increased 129% to 20.6 million.”
Comparable technology companies include: Activision Blizzard Inc. (Nasdaq: ATVI - News), Electronic Arts Inc. (Nasdaq: ERTS - News) and Take-Two Interactive Software Inc. (Nasdaq: TTWO - News).
http://finance.yahoo.com/news/Amico-Games-Corp-Rated-bw-2864035139.html?x=0&.v=1
AMCG - Price Target of $1.44
Amico Games Corp. Rated 'Speculative Buy,' by Beacon Equity Research with a Price Target of $1.44
On Monday February 8, 2010, 2:18 pm EST
DALLAS--(BUSINESS WIRE)--Amico Games Corp. (OTCBB:AMCG - News) has been rated “Speculative Buy,” with a price target of $1.44 by Beacon Analyst, Victor Sula, Ph.D.
The full report is available at http://www.beaconequity.com.
Anyone interested in receiving alerts regarding AMCG research should e-mail members@beaconequity.com with “AMCG” in the subject line.
In the report, the analyst details the interactive entertainment media company, stating:
“The Company plans to accelerate its growth pace in 2010 and 2011 by licensing additional games and technologies and further expanding its registered user base. … We think these growth initiatives could increase the Company’s revenues to more than $10 million and net income to more than $5 million by fiscal year-end 2012.
“The Company’s revenues increased almost 40% in FY 2009 and 61% year-over-year in Q1 2010. In the past 12 months, the number of total game-registered users increased 129% to 20.6 million.”
Comparable technology companies include: Activision Blizzard Inc. (Nasdaq: ATVI - News), Electronic Arts Inc. (Nasdaq: ERTS - News) and Take-Two Interactive Software Inc. (Nasdaq: TTWO - News).
http://finance.yahoo.com/news/Amico-Games-Corp-Rated-bw-2864035139.html?x=0&.v=1
Green, green and more green, absolutely superb.
http://investorshub.advfn.com/boards/read_msg.aspx?Message_id=44216122&txt2find=amcg
Shoot 'Bullish', I'm still living on old news and projections. Latest news released in the last month or so is just gravy and great, you know what I mean?
Old post off of news:
Some simple calculations on AMCG from todays news show that for the three(3) months ended October 31:
Approx: 1,700,000 new users x $7.00 per game is $11,900,000 revenue per quarter.
If that continues at "just" the same pace for a full year?
11,900,000x4=YOWZA.
That's not taking into account the already established users that will continue.
Should be expecting huge things for Aimco Games Corp. going forward.
http://www.amicogames.com
I hear ya, Glad I'm still holding a few after trading AMCG from the November-December run, know what I mean?
Things may be looking good/better here for a while coming, don't you think?
Got a breakout alert from 'SmallCapSociety' on friday and it's amazing looking around, a lot of exposure and attention.
World market certainly seems to be heading that way and potentially beyond, doesn't it?
http://www.goldprice.org/gold-price.html
Gold as been accepted as a store of value throughout human history because of its beauty, durability, divisibility, consistency, and rarity. Owning gold is always an asset and can never be considered a liability since there is no future obligation to any entity arising from past transactions or events. This makes gold the ultimate hedge against any fiat currency.
Yup, and some simple math for AFYG's potential gold values per filed documentation.
Estimate of 1,819,800 oz's x current market value of approximately $1105 per oz = $2,010,879,000
http://www.goldprice.org/gold-price.html
http://www.affinitygold.com/present/Affinity_Technical_Report_Nov_2009_FINAL.pdf
Yup, and the bottom line of page 37 of the published N.I. 43-101 reports makes a big statement, doesn't it?
"APPENDICES
Appendix A ..................................... 26
Phase 1 — 2010 Mining Operation
• Financial Review
• Engineer’s Estimate
• Existing Equipment & Plant
• Additional Equipment & Plant Recommendations"
Agree - AFYG - with gold prices on the increase and over $1100.00 per oz. it is pretty simple, isn't it?
BUY GOLD!
http://www.goldprice.org/gold-price.html
Yup, Believe we could also, has been doing well to this point.
Posted by: TripleL Date: Friday, February 12, 2010 10:10:54 AM
In reply to: moneycoach who wrote msg# 694 Post # of 804
Decent trading here the last two weeks.
Opened on Monday, 02/01/10, @ $1.61
Closed on Friday, 02/05/10 @ $1.83
Opened on Monday, 02/08/10, @ $1.83
Current this morning Friday, 02/12/10, $1.85($1.88) with a high this week of $1.91.
Accumulation and money flow indicators have been strong and doing well.
Now with the frontline experience that Antoniazzi brings as the new CEO:
"...he was responsible for the engineering, construction, procurement, and commissioning of $473 million of projects at 8 different sites." ~ "...he built plants in Australia, Brazil, Turkey, Canada and USA valuing over $120 million."
2010 Planned Accomplishments
1.Raise $1 Million in Q1; and, up to another $3 Million in Q2
2.Put flagship project into production by end of Q2
3.Continue with the second phase of the Company's planned exploration program to attempt to quantify the fine gold available on the property as well as increase the Measured, Indicated and Inferred reserves published in first release of the Company's N.I. 43-101 Report
4.Secure additional concession rights to become the single largest contiguous concession rights holder in the area.
Antonio Rotundo, CEO of Affinity Gold, said "Over the last year, we have made great strides in bringing our Company to point where we are well positioned to begin production on our property. It is an exciting time as we are about to begin reaping the fruits of our labor."
AFYG - Affinity Gold Corp. Announces CEO Appointment
On Thursday February 11, 2010, 8:45 am EST
MAPLE GROVE, Minn., Feb. 11 /PRNewswire-FirstCall/ -- Affinity Gold Corp. (OTC Bulletin Board: AFYG) ("Affinity" or the "Company") is pleased to announce the appointment of mining executive Paul Antoniazzi as Chief Executive Officer of the Company. Mr. Antoniazzi has been a Board member of Affinity Gold since January of 2009.
Mr. Antoniazzi brings with him over 25 years of extensive experience and a successful track record in senior management positions within international mining organizations. As a former senior project manager of North America for Lac Minerals Inc., (now Barrick Gold Corp.) (1983-1994), he was responsible for the engineering, construction, procurement, and commissioning of $473 million of projects at 8 different sites. As Vice president of Golder Paste Technologies (1994-2002) he built plants in Australia, Brazil, Turkey, Canada and USA valuing over $120 million. Since 2002, he has worked as an independent contractor specializing in environmental and mining projects. He currently sits on the board of three Canadian listed mining companies, Opawica Explorations Inc. (TSX: OPW), International Kirkland Minerals Inc., (IKI-TSXV), and RT Minerals Corp. (C.RTM: CNQ).
Mr. Antonio Rotundo, President, CFO and Director of the Company, stated, "The Board and I very much look forward to working with Mr. Antoniazzi in his new capacity and believes he brings significant mining experience to the Company particularly in the areas of project development and operations. Mr. Antoniazzi will work closely with the board and I to develop, evaluate and implement both operational and strategic initiatives of the Company."
Immediately prior to the appointment of Mr. Antoniazzi as CEO, Mr. Antonio Rotundo stepped down as CEO but remains as the President, CFO and a Director of the Board for Affinity Gold.
Mr. Antoniazzi said, "After spending the better part of the last year as an active board member of Affinity Gold and understanding the true potential of our find, it is extremely exciting to be in a position to lead our Company to the next level."
http://finance.yahoo.com/news/Affinity-Gold-Corp-Announces-prnews-2737434871.html?x=0&.v=1
Last eleven(11) trading days have been looking real good. Expecting more to come here.
* Money flow is strong.
* Accumulation is strong.
* Volume by price shows buying, desire to hold with increased expectations from these levels.
* Psar flipped.
* Nice solid and steady pps increase, pull-back and strong recovery on a Friday.
* And the oblique angles on the retrace are projecting continued upward direction it looks like.
News from the company, along with the already published reports, readily available, which most all have seen, reading, dd'ing, and this baby has the potential to start moving/running like a friggen' "raped ape"!
Looking forward to it as well.